KC Pharmaceuticals Inc., based in Pomona, California, has voluntarily removed over three million bottles of over-the-counter eye drops from the U.S. market. This decision follows a warning from the Food and Drug Administration (FDA) about the company's inability to ensure sterile manufacturing conditions.
Specifically, 3,111,072 bottles were distributed through major retail chains such as CVS, Walgreens, Rite Aid, Kroger, H-E-B, Publix, Harris Teeter, Meijer, Dollar General, and Circle K, among others, and are now being recalled.
The recall process began on March 3, and the FDA classified it as a Class II recall on March 31. This classification indicates that while the health effects are "temporary or medically reversible," the chance of severe complications is minimal.
The lack of guaranteed sterility doesn’t necessarily imply contamination, but it does indicate that the manufacturing process couldn't confirm the prevention of possible microbial contamination.
Variety of Brands and Products Implicated
The recall involves eight different types of products, all in 15 ml bottles, sold under various brand names. These include "Dry Eye Relief Eye Drops", "Sterile Eye Drops," "Artificial Tears Sterile Lubricant Eye Drops," "GeriCare Artificial Tears Lubricant Eye Drops," "CVS Lubricant Eye Drops Redness Reliever," and "CVS Lubricant Eye Drops Dry Eye."
The largest segment of the recall consists of over a million bottles of Dry Eye Relief Eye Drops, which were distributed through Rite Aid, H-E-B, and Harris Teeter.
Identifying Affected Products
Consumers can identify the affected products by checking the lot codes on the labels. These codes begin with AC, AR, LT, SU, RG, RL, SY, or AT, with expiration dates ranging from April to October 2026.
To date, there have been no health injuries or adverse effects reported in connection to these recalled products.
Retailers and Manufacturer's Response
In a Class II recall, the FDA advises that consumers may continue using the product unless otherwise instructed by the company or the agency.
CVS has confirmed that it has removed these items from all physical stores and CVS.com, implementing a "Do Not Sell" alert at checkout to prevent further sales. A CVS spokesperson stated, "We are committed to ensuring that the products we offer are safe, perform as intended, comply with regulations, and meet our customers’ needs." Additionally, customers who purchased these eye drops can return them to any CVS location for a refund.
KC Pharmaceuticals has yet to comment publicly on the recall, and the exact cause of the decision remains unclear.
FDA's Ongoing Concerns Over Eye Drop Sterility
This situation fits into a broader pattern of FDA warnings about sterility issues with eye drops. A more severe case occurred in 2023 when EzriCare Artificial Tears were found contaminated with an antibiotic-resistant bacterium, resulting in over 80 infections across at least 18 states, 14 cases of permanent vision loss, and four fatalities.
Unlike the EzriCare incident, which was classified as a Class I recall due to high risk, the current recall for KC Pharmaceuticals is deemed Class II, indicating a lower risk of serious health consequences.
Understanding Eye Drop Recalls and Safety
What prompted the recall of KC Pharmaceuticals' eye drops?
The recall was initiated due to the FDA's warning about the lack of assurance in the sterility of the manufacturing process, though no contamination was confirmed.
How can consumers identify the recalled eye drops?
Affected products can be identified by lot codes starting with AC, AR, LT, SU, RG, RL, SY, or AT, and have expiration dates between April and October 2026.
What should consumers do if they have purchased the affected products?
Consumers should return the affected eye drops to the place of purchase for a refund. CVS has confirmed they will accept returns at all their locations.